PolyNovo Limited (ASX:PNV)
Australia · Delayed Price · Currency is AUD 0.9950
+0.0250 (2.58%)
At close: Feb 5, 2026
PolyNovo Market Cap
PolyNovo has a market cap or net worth of 687.39 million as of February 5, 2026. Its market cap has decreased by -55.97% in one year.
Market Cap
687.39M
Enterprise Value
670.94M
Revenue
128.70M
Ranking
n/a
PE Ratio
52.65
Stock Price
1.00
Market Cap Chart
Since August 23, 1999, PolyNovo's market cap has increased from 33.09M to 687.39M, an increase of 1,977.51%. That is a compound annual growth rate of 12.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 670.12M | -21.14% |
| Dec 31, 2025 | 849.74M | -39.71% |
| Dec 31, 2024 | 1.41B | 23.37% |
| Dec 29, 2023 | 1.14B | -17.80% |
| Dec 30, 2022 | 1.39B | 37.79% |
| Dec 31, 2021 | 1.01B | -60.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4DMedical | 2.11B |
| Anteris Technologies Global | 837.17M |
| Aroa Biosurgery | 239.80M |
| Lumos Diagnostics Holdings | 213.96M |
| EMVision Medical Devices | 168.22M |
| SomnoMed | 141.99M |
| Cleo Diagnostics | 91.70M |
| Compumedics | 76.91M |